TY - JOUR
KW - Adult
KW - Biopsy
KW - Capsules
KW - Clinical Trials as Topic
KW - Humans
KW - Isoniazid
KW - Leprostatic Agents
KW - leprosy
KW - Male
KW - Serotonin
KW - Time Factors
AU - Antia N H
AU - Ambrose E J
AU - Upleker M W
AU - Mahadevan P R
AU - Mester L
AB - <p>To examine the anti-leprosy effect of deoxyfructoserotonin the drug was given in a dose of 10 mg/kg for 6 months to 6 patients with active lepromatous leprosy, in accordance with the WHO-THELEP protocol. Clinical and histological assessment and mouse foot-pad studies suggest that the drug has some anti-leprosy effect.</p>
BT - Lancet (London, England)
C1 - http://www.ncbi.nlm.nih.gov/pubmed/2894551?dopt=Abstract
DA - 1988 Mar 19
DO - 10.1016/s0140-6736(88)91417-1
IS - 8586
J2 - Lancet
LA - eng
N2 - <p>To examine the anti-leprosy effect of deoxyfructoserotonin the drug was given in a dose of 10 mg/kg for 6 months to 6 patients with active lepromatous leprosy, in accordance with the WHO-THELEP protocol. Clinical and histological assessment and mouse foot-pad studies suggest that the drug has some anti-leprosy effect.</p>
PY - 1988
SP - 619
EP - 22
T2 - Lancet (London, England)
TI - Effect of deoxyfructoserotonin (DFS) on lepromatous leprosy.
VL - 1
SN - 0140-6736
ER -